Arcus Biosciences, Inc.
RCUS· NYSE
RCUSArcus Biosciences, Inc.
Filed May 9, 2022 · 10-Q · 39 days after period end · 0000950170-22-008502
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $18.00M | $9.46M | $1.75M | $1.75M |
| Net Income | -$68.00M | -$72.59M | -$27.75M | -$17.67M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcus Biosciences, Inc. · CIK 1724521 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 9, 2022 · 39 d after period end
